60
Participants
Start Date
September 1, 2022
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2024
Shenxiao Yuning decoction
Astragalus 30g, Radix Pseudostellariae 15g, Rehmannia glutinosa 15g, Rhodiola rosea 12g,Cimicifuga 15g,Cuttlebone 15g,Poria 15g,Cicada degeneration 9g,Rheum palmatum 6g.
Symptomatic treatment
(i) Diabetes education: all study participants were given dietary guidance for diabetic nephropathy, low-fat, high-quality, low-protein diet, and restricted sodium intake; maintain emotional stability, quit smoking and alcohol, and exercise appropriately; (ii) control of blood glucose: all study participants routinely received hypoglycaemic treatment, hypoglycaemic measures are not limited (including oral hypoglycaemic drugs or insulin injection); (iii) Control of lipids: study participants with substandard lipids routinely receive lipid-lowering treatment; (iv) Control of blood pressure: those with blood pressure \>140/90 mmHg should be treated with antihypertensive drugs to control blood pressure, and antihypertensive measures are not limited (CCB class, ACEI or ARB class, α, β-blockers, diuretics, etc.); ⑤ Other symptomatic treatment.
The First Affiliated Hospital of Shandong First Medical University, Jinan
Lin Liao
OTHER